|
September 9, 1999
News this month
Mitral valve prolapse: not as common or as serious as thought
Good news for hundreds of thousands of people who may have been
misdiagnosed with mitral valve prolapse. Two studies in the July
1 issue of the New England Journal of Medicine conclude the
condition has been widely over-diagnosed.
Mitral valve prolapse had been considered the most common cardiac
disease in young people, particularly women, and the most common
heart valve disease in people of all ages, affecting as many as
35 percent of the population. These new studies indicate it affects
only 2.4 percent of the population. And even those who have it do
not face a high risk of stroke or heart failure, which were considered
relatively common complications.
Thought to affect as much as 35% of
the population. . .new studies indicate mitral valve prolapse affects
only 2.4%.
What is mitral valve prolapse?
Mitral valve prolapse (MVP) describes what happens when the two
flaps in a valve on the left side of the heart fail to close properly,
allowing blood to backwash from the left ventricle into the atrium.
This can upset the hearts rhythm, overwork the heart or lead
to infection. Symptoms, when they occur, include shortness of breath,
chest pains and palpitations. See
an animation of mitral valve prolapse.
Framingham Heart Study
Using improved criteria for diagnosis of the defective valve, a
group led by Dr. Lisa A. Freed evaluated 1,646 men and 1,845 women
and found only 2.4 percent of the population has the usually benign
defect. They also found men were just as likely to suffer from the
condition as women. Until now, MVP was thought to be more common
among women.
The subjects of the study were offspring of the original subjects
of a large epidemiological investigationcalled the Framingham
Heart Studyand their spouses. Diagnoses were based on findings
revealed by current two-dimensional echocardiograms using refined
criteria for the diagnosis of mitral valve prolapse. The methodology
used in the 1970s and 1980s has been recently improved and false
positive diagnoses have been minimized.
Two-dimensional echocardiograms using
refined criteria for diagnosis are reducing the number of people
incorrectly diagnosed as having mitral valve prolapse.
Only 84 of the participants were found to have MVP. And among those
84, only five had serious complications, about the same as the general
population. Why is the percentage so much less than those found
in previous studies which associated serious complications with
the diagnosis? The studys authors attribute the difference
to the population sample. Older studies were conducted in university
teaching hospitals where the most seriously ill patients are referred.
This study was conducted in Framingham, Mass., a community more
representative of the general population.
Massachusetts General Hospital Study
Previous studies have shown between 28 and 40 percent of people
who have had strokes have mitral valve prolapse, indicating the
possibility the condition might be a risk factor for stroke. The
incidence has been reported as even higher among patients younger
than 45 years.
Authors of this study examined data on 213 patients 45 years of
age or younger who had experienced strokes between 1985 and 1995.
All of the subjects were evaluated using the newest diagnostic imaging
criteria for detection of MVP.
Previous studies indicated MVP might
be a risk factor for stroke, but a new study finds no association
between the two.
Four of the 213 patients, or 1.9 percent, were diagnosed with mitral
valve prolapse compared to 2.7 percent in a control group, indicating
no association between the incidence of stroke and MVP. 
Diagnosing mitral valve prolapse
A two-dimensional echocardiogram using state-of-the-art
technology, as well as newly evolved criteria for diagnosing
mitral valve prolapse, is available at Yale-New Haven Hospital
and at the offices of cardiologists affiliated with Yale-New
Haven. If you have a diagnosis of mitral valve prolapse
you would like to have re-evaluated, call your doctor or
1-888-700-6543 for a referral to a cardiologist affiliated
with Yale-New Haven Hospital. |
Physician Referral Online
A free and confidential service
of Yale-New Haven Hospital.
Physician Referral Online
Using your own criteria, you can request information from a database
of 900 area physicians who have registered to participate.
Request an appointment
We would be happy to assist you in scheduling an appointment with
a member of the hospital's medical staff. Use the link above or
call:
203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.
|
|
Mitral valve prolapse frequently misdiagnosed
I strongly suggest that anyone diagnosed with mitral valve prolapse
several years ago be retested. New diagnostic imaging technology
has made it possible for us to understand the true anatomy of
this valve. Before, physicians believed a normal mitral valve
was shaped like a saucer. When scans were taken with older echocardiography
technology, doctors believed bulges in the valve were an indication
of prolapse. The bulges were actually quite normal.
Relying on scans taken with older
echocardiography technology, doctors believed bulges in the valve
were an indication of prolapse. The bulges were actually quite
normal.
We now know that mitral valves are more saddle-shaped, and we
have much more accurate criteria for determining if someone in
fact does have mitral valve prolapse. We used this updated criteria
in the study we did in Framingham on nearly 3,500 men and women.
We found slightly more than 2 percent of the population has the
condition and only a small percentage of those patients, less
than 5 percent, have serious complications such as stroke, atrial
fibrillation or congestive heart failure--the same incidence as
the general population.
A relief for the misdiagnosed
In the 1970s and 1980s, there was a dramatic spike in the incidence
of MVP diagnoses, particularly in young women with unexplained
chest pain or heart palpitations. New ultrasound technology enabled
physicians to examine hearts easily, and the diagnosis increased
in popularity.
And in the 1980s, when several studies showed a high prevalence
of prolapse among stroke victims, the condition was linked to
stroke in younger patients. Hospital-based studies also indicated
the condition could lead to a number of serious complications
like heart failure, stroke, reduced blood flow and infection within
the heart.
Many people mistakenly diagnosed with mitral valve prolapse
lived in constant fear of developing serious complications. They
also were considered high risk by insurance companies and could
be eliminated from certain kinds of physically demanding jobs.
These individuals were also required to take antibiotics every
time they underwent a dental procedure to prevent a potentially
fatal infection.
The new diagnostic criteria and the results of the two studies
in the New England Journal will eliminate this needless
anxiety and unnecessary and costly precautions.
The complication rate of patients
accurately diagnosed with prolapse is no greater than the general
population.
The complication rate of patients who are accurately diagnosed
with prolapse is no greater than the general population. Earlier
research that indicated many patients were at risk of serious
complication was done in large referral centers where the most
seriously ill patients were seen, skewing the results. Our study,
conducted in a community more representative of the general population,
eliminated this bias.
If you have MVP
If you have been diagnosed with prolapse, confirm with your doctor
that recent echocardiogram technology was used to make the diagnosis.
If not, ask to be retested.
If you do have the condition, understand most cases do not lead
to serious complications. Follow your physicians advice
concerning regular checkups and discuss treatment options. In
severe cases, valves can be surgically repaired or replaced with
artificial valves. 
Dr. Freed, who was the lead author in the research article
based on the Framingham Heart Study, is an associate with The
Cardiology Group with offices in New Haven and Branford. She is
an attending physician at Yale-New Haven Hospital.
|